The Prognostic Value of Androgenetic Alopecia and Benign Prostatic Hyperplasia in Men with COVID-19: A Prospective Multidisciplinary Observational Study of 766 Patients from Turkey

    October 2022 in “ Journal of health sciences and medicine ”
    Çağrı Turan, Nurcan Metin, Türkantuğba YILDIZ>, Selcen CAFEROĞLU SKAT>, Ahmet Emre Cinislioglu, Nazan CİNİSLİOĞLU
    TLDR Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.
    This study evaluated 766 men with COVID-19 in Turkey to assess the prognostic value of androgenetic alopecia (AGA) and benign prostatic hyperplasia (BPH). The study found no significant prognostic value of AGA in younger patients, but middle-aged and elderly patients with the Gabrin sign showed poorer outcomes in terms of oxygen saturation and lymphocyte count. Although AGA was not a significant prognostic indicator, hospitalization rates were notably higher in middle-aged and elderly patients with BPH, suggesting a potential link to the androgen-mediated COVID-19 severity hypothesis. However, no significant relationship was found between BPH and ICU transfer or mortality.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results

    Related Community Posts Join

    6 / 1000+ results

      community 1 month of using fin, so happy

      in Progress Pictures  865 upvotes 4 months ago
      User had a hair transplant and used a finasteride and minoxidil spray for 6 months with no results. After adding finasteride tablets for 1 month, they saw significant hair growth improvement.

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

      community Why does finasteride stop working?

      in Finasteride/Dutasteride  26 upvotes 2 months ago
      Finasteride may seem less effective over time due to increased DHT sensitivity or aging, but it still suppresses DHT. Switching to dutasteride offers stronger DHT suppression but may increase estrogen levels.

    Similar Research

    5 / 1000+ results